- Medical linear accelerators (LINACs) are vital devices used in external beam radiation therapy to treat cancer by delivering high-energy X-rays or electrons directly to the tumor while sparing surrounding healthy tissue. They are central to the delivery of precise, targeted radiotherapy across a wide range of cancer type
- The demand for LINACs is significantly driven by the rising global cancer burden, technological advancements in radiation therapy, and increasing preference for non-invasive treatment options. Breast, prostate, and lung cancers are among the leading indications fueling the need for these devices globally
- North America stands out as one of the dominant regions for medical linear accelerators, supported by well-established oncology centers, favorable reimbursement policies, and continuous investment in healthcare innovation
- For instance, the U.S. has witnessed steady growth in the installation of advanced LINAC systems in both urban and regional cancer centers, enhancing patient access to precision radiotherapy and driving the region's leadership in treatment outcomes
- Globally, medical linear accelerators rank as the most critical equipment in radiotherapy departments, forming the backbone of modern cancer treatment infrastructure and playing a pivotal role in improving survival rates through targeted, high-precision therapy
